6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
14m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
14m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
38m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
38m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
38m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Basilea Pharmaceutica Ag (SW:BSLN) — investor relations, events, news, and company updates on 6ix.

Latest News

Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420

Basilea announces start of first‑in‑human study of novel antibiotic BAL2420

Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

Financials

Revenue

CHF232.38 M

Market Cap

CHF676.2 M

P/E Ratio

17.55

EPS

3.14

Community Chat

Ask AI